Parametric Portfolio Associates’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$1.93M	Buy	30,725 +5,696	+23%	+$358K	﹤0.01%	2436
2021 Q4	$1.9M	Buy	25,029 +10,840	+76%	+$822K	﹤0.01%	2466
2021 Q3	$1.59M	Sell	14,189 -458	-3%	-$51.3K	﹤0.01%	2558
2021 Q2	$2.37M	Buy	+14,647	New	+$2.37M	﹤0.01%	2332